It is important to note that although decreased β-cell insulin production and insulin resistance induced by Gcs may lead to the induction of type II diabetes or aggravation of pre-existing diabetes in patients [47], CpdA did not impair glucose metabolism, suggesting a reduced risk for induced type II diabetes by this GR ligand. Here, NR3C1 is linked to type 2 diabetes mellitus.